Does Swedish Life Science have a future?

There is a focus on life science this fall. Many wonder whether Pfizer will make a renewed offer to AstraZeneca or not. At the same time, the Swedish government will decide on a national strategy for life science, based on a study presented on October 31.

On Wednesday October 8, Swedish Entrepreneurship Forum arrange  a seminar on life science from a Swedish perspective. Speakers will include Leif Johansson, Hans Wigzell, David Brown and Susanne Ås Sivborg.

The discussions will cover:

  • What is the Life Science sector in Sweden today?
  • What can the Swedish government do to stimulate Swedish Life Science?
  • How can Sweden maintain an internationally strong position in Life Science?
  • Have LifeScience a future in Sweden?

Note: The seminar is held in both Swedish and English.


Lars Backsell, Founder and Chairman, Recipharm
Pontus Braunerhjelm, CEO, Swedish Entrepreneurship Forum and Professor, KTH Royal Institute of Technology
David Brown, Professor, Cambridge
Johan Eklund, Research Director, Swedish Entrepreneurship Forum (moderator)
Leif Johansson, Chairman, Astra Zeneca
Sarah Lidé, Senior Advisor, PwC
Per-Erik Sandlund, CEO, Pesab AB
Hans Wigzell, Former Head of Karolinska Institutet
Susanne Ås Sivborg, Director General Swedish Patent and Registration Office and coordinator for Swedish Life Science

When? Wednesday October 8, 1.30 pm – 5.15 pm. Registration from 1 pm.
Where? Wallenbergsalen, IVA Konferenscenter, Grev Turegatan 16, Stockholm.
How? RSVP to Britt-Marie Nordström, 019-33 37 00.


Följ oss på: